A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Last updated:
2026-09-26
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LUTIKIZUMAB IN ADULT AND ADOLESCENT SUBJECTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA

Intervention/treatment:
LUTIKIZUMAB (ABT-981)
Medical condition:
HIDRADENITIS SUPPURATIVA
Protocol code:
M20-465
Control number:
288777
Status:
Active, not recruiting
Approved:
August 19, 2024
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT06468228
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
12 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
ABBVIE CALL CENTER
Role
CONTACT
Phone:
844-663-3742
Sponsor
ABBVIE CORPORATION

Locations

Alberta

Beacon Dermatology /ID# 264262
Calgary, Alberta, T3A 2N1
Recruiting
Rejuvenation Dermatology - Edmonton Downtown /ID# 265963
Edmonton, Alberta, T5J 3S9
Recruiting
Stratica Dermatology /ID# 265856
Edmonton, Alberta, T5K 1X3
Recruiting

British Columbia

Interior Dermatology Centre - Probity - PPDS /ID# 266202
Kelowna, British Columbia, V1W 4V5
Recruiting

New Brunswick

Brunswick Dermatology Center /ID# 264260
Fredericton, New Brunswick, R3M 3Z4
Recruiting

Newfoundland and Labrador

Karma Clinical Trials /ID# 265962
St. John's, Newfoundland and Labrador, A1A 4Y3
Recruiting

Ontario

Centre de Recherche Saint-Louis /ID# 265855
Quebec, Ontario, G1W 4R4
Recruiting
Derm Care Clinic /ID# 265261
Mississauga, Ontario, L4W 0C2
Recruiting
DermEffects /ID# 265262
London, Ontario, N6H 5L5
Recruiting
FACET Dermatology /ID# 265267
Toronto, Ontario, M4C 1L1
Recruiting
Leader Research /ID# 266114
Hamilton, Ontario, L8L 3C3
Recruiting
Private Practice - Dr. Kim Papp Clinical Research /ID# 265266
Waterloo, Ontario, N2J 1C4
Recruiting
Skin Health /ID# 267735
Cobourg, Ontario, K9A 0Z4
Recruiting
Name
Site Coordinator
Role
CONTACT
Phone:
(289) 252-1856
York Dermatology Clinic and Research Centre /ID# 265265
Richmond Hill, Ontario, L4C 9M7
Recruiting

Quebec

Private Practice - Dr. Angelique Gagne-Henley /ID# 264263
Saint-Jérôme, Quebec, J7Z 7E2
Recruiting

Saskatchewan

Diex Recherche Quebec Inc. /ID# 265263
Quebec, Saskatchewan, G1V 4T3
Recruiting
Name
Site Coordinator
Role
CONTACT
Phone:
306-664-7546
SkinSense Dermatology /ID# 265964
Saskatoon, Saskatchewan, S7K 0H6
Recruiting
Did you find what you were looking for?